SOX2 and lung carcinoma: In addition, higher SOX2 levels have been reported to correlate with poorer prognosis in cancers, such as breast, colorectal, oesophageal, ovarian, prostate, and lung cancer as well as in nasopharyngeal and sinonasal carcinoma32,33,35–42.